Last reviewed · How we verify

NCT06101160

Botulinum Toxin Injection for Sialorrhea in Cerebral Palsy

Completed Last updated 27 October 2023
What this trial tests

trial testing onaBoNT-A in Sialorrhea in 61 participants. Completed in 30 April 2023.

Timeline
30 June 2021
Primary endpoint
1 May 2022
30 April 2023

Quick facts

Lead sponsorCairo University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment61
Start date30 June 2021
Primary completion1 May 2022
Estimated completion30 April 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 4 to 12, any sex, with Sialorrhea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A 100 units of botulinum toxin was injected in both parotid and submandibular glands for children (2 - 12 years) with incapacitating sialorrhea in juvenile cerebral palsy patients and they are followed up for 1 year

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of onaBoNT-A

Trials testing the same drug.

Other recruiting trials for Sialorrhea

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06101160.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing